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Abstract
Introduction. Critical limb ischemia (CLI) is a vascular disease that has a significant amputation and mortality risk with diabetes mellitus; the
most significant risk factor in CLI is prevalent among Indonesian. Endovascular intervention (EVI) is preferred in treating CLI because it is noninvasive and effective. Balloon angioplasty and stent angioplasty are the most common method of EVI in Indonesia. This study aims to compare
the effectiveness of balloon angioplasty and stent angioplasty on wound healing in CLI.
Method. A cross sectional study enrolled 90 subjects of CLI who underwent endovascular intervention using balloon angioplasty dan stent
angioplasty from January 2013 to July 2017 in dr. Cipto Mangunkusumo General Hospital, Jakarta. The wound healing period between balloon
angioplasty dan stent angioplasty analysed using an unpaired T-test.
Results. The wound healing period in balloon angioplasty and stent angioplasty distributed normally. The mean value of the wound healing period
in balloon angioplasty and stent angioplasty is 84.8 ± 2.423 and 59.93 ± 2.423 days with a mean difference of 25 days. The difference in the wound
healing period in both groups is statically significant.
Conclusion. Stent angioplasty is a better method than balloon angioplasty for wound healing in patients with CLI.
Keywords: Critical limb ischemia, endovascular intervention, wound healing

Introduction

Method

Critical limb ischemia (CLI) is a condition characterized
predominantly by resting pain and ischemic ulcer or gangrene.
It has a high risk of amputation as well as a high mortality rate.1
The incidence of peripheral artery disease (PAD), especially
CLI, reached 500 – 1,000 new cases per one million-year in the
United States. CLI prevalence has been increasing due to the
high incidence of diabetes mellitus.2 In Indonesia, diabetes
mellitus incidence showed increasing number, i.e., 5.7% in
2017 to 6.9% in 2013.3 Purwanti (2013) stated that out of 1,785
diabetic patients, 21% of them had microvascular complication
as PAD.4 In PAD, there is a progressive atherosclerosis process
in arterial vessels, especially in the legs. Iliac, femoral, and
popliteal arteries are the most common affected sites.5

This study was a cross-sectional analytic design that compared
the duration of wound healing in CLI patients treated by
balloon angioplasty versus stent angioplasty. The study
conducted at dr. Cipto Mangunkusumo General Hospital.
Subjects were CLI patients treated by balloon angioplasty or
stent angioplasty by the Vascular Surgery Division of dr. Cipto
Mangunkusumo General Hospital on January 2013 – May
2017. Sampling enrolled by consecutive sampling methods
based on medical records. Based on the calculation, the
minimal sample was 88 subjects. Exclusion criteria were
incomplete data on medical records. The Committee ethic of
Faculty Medicine, Universitas Indonesia, approved this study.

The optimal treatment for CLI is the revascularization of the
occluded arteries. Bypass surgery and endovascular
intervention (EVI) are standard techniques used for CLI
treatment.6 EVI considered superior to bypass surgery due to
better limb salvage.7 In CLI, wound healing is the cause of low
quality of life and high medical fare.8 Karawanda (2012) in his
study stated that wound healing achieved in 80% of patients
within 54 days and 97% in 145 days after EVI. 9 Specifically,
the two most common EVI techniques were balloon
angioplasty (or percutaneous transluminal angioplasty [PTA])
and stent angioplasty, which has different wound healing
duration.10 In the 1-year follow-up, patients treated with
balloon angioplasty had a 67.9% cure rate and patients treated
with stent angioplasty had a 73.6% cure rate. 11.

Data collected from medical records including subjects'
characteristic (age, gender, body mass index, smoking history),
clinical data (amputation history, resting pain, ankle-brachial
index, ulcer location), laboratory data (hemoglobin, hematocrit,
white blood cells, platelet count, serum glutamic oxaloacetic
transaminase, serum glutamic pyruvic transaminase, urea,
creatinine, prothrombin time, activated partial thromboplastin
time, cholesterol, triglyceride, fasting blood glucose, HbA1C),
EVI method, duration of wound healing.
Statistical Package conducted the statistical analysis for the
Social Sciences (SPSS) version 20.0 software. Hypothesis test
was done by unpaired T-test, followed by the Mann-Whitney
test.
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The study approved by the Committee of Ethics, Faculty of
Medicine, Universitas Indonesia No 1112/UN2.F1/ETIK/2017.
Results
Subjects' characteristics presented in Table 1. The mean age of
subjects was 58 years old, and most of them were males. The
most common location of CLI was a right leg, followed by the
left leg and both legs. Essential characteristics were not
significantly different between patients in the balloon
angioplasty group and stent angiography group. The statistical
difference found in blood glucose level, HbA1C, and body
mass index data (Table 1).

CLI patients treated with balloon angioplasty had a mean
wound healing duration of 84.8 days versus 59.3 days in
patients treated with stent angioplasty. There was a 25-days
(SD 2.4) difference in the wound healing duration between the
two groups, which was statistically significant (p = 0.000).
Amputation and resting pain stated as outcomes and the
difference of those outcomes presented in Table 2. Amputation
incidence and resting pain status were not statistically different
between the two groups

Table 1. Subjects’ characteristics

58.7 ± 10.55

Balloon Angioplasty
(n = 46)
59.1

Stent Angioplasty (n
= 44)
58.3

46 (51.1)
44 (48.9)

20
26

26
18

0.139

38 (42.2)
36 (40)
16 (17.8)

23
19
4
0

15
17
10
2

0.097

11.15
33.2
12.100
230000
32
25
31.6
0.9
0.9
1
185
151.5
166
7

11.35
33.7
10.560
246000
41.5
25
30.5
0.8
1
1
197.5
151.5
143
6.25

0.637
0.620
0.191
0.248
0.131
0.326
0.634
0.451
0.609
0.648
0.256
0.997
0.014*
0.022*

Value (N = 90)
Age, mean (standard deviation)
Gender, n (%)
Males
Females
Location, n (%)
Right leg
Left leg
Both legs
Aortoiliac disease
Affected vessels, n (%)
Femoral artery
Iliac artery
Popliteal artery
Anterior tibia artery
Posterior tibia artery
Peroneal artery
Pre-intervention blood laboratory works
Hemoglobin, mean (SD)
Hematocrit, mean (SD)
White blood cells, mean (SD)
Platelet, mean (SD)
SGOT, mean (SD)
SGPT, mean (SD)
Urea, mean (SD)
Creatinine, mean (SD)
PT, mean (SD)
aPTT, mean (SD)
Total cholesterol, mean (SD)
Triglyceride, mean (SD)
Random blood glucose, mean (SD)
HbA1C, mean (SD)

P value
0.709

52 (46.8)
6 (5.4)
24 (21.7)
14 (12.6)
12 (10.8)
3 (2.7)

11.3 (7.6-14)
34 (23-42)
11.215 (3000-115000)
233.500 (13000-726000)
34 (10-375)
25 (7-267)
31 (11-193)
0.9 (0.1-10.6)
1 (0.8-1.4)
1 (0.8-1.7)
190 (59-310)
151.49 ± 25.93
155.5 (26-350)
6.9 (5.2-8.8)

Basic clinical conditions
Smoking habit, n (%)
Diabetes mellitus, n (%)
BMI, mean (SD)
Resting pain, n (%)
Right ABI, mean (SD)
Left ABI, mean (SD)

17
20
0.413
37 (41.1)
33
20
0.011*
53 (58.9)
23.87
23.39
0.598
23.63 ± 4.35
158.5
161.2
0.057
87 (96.7)
43
44
0.494
0.85±0.2
0.87
0.84
0.479
0.8 (0.3-1.2)
0.8
0.7
0.069
SGOT: serum glutamic oxaloacetic transaminase, SGPT: serum glutamic pyruvic transaminase, PT: prothrombin time, aPTT: activated partial thromboplastin time,
ABI: ankle-brachial index, BMI: Body Mass Index
Table 2. The comparison of outcome between alloon angioplasty versus stent angioplasty
Outcome
Balloon angioplasty
(n = 46)
Amputation
22
Resting pain
̶
Resolved
4
̶
Improving
40
2
̶
Unchanged

Stent angioplasty
(n = 44)
16
3
41
0

P value
0.271

0.348
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In terms of postoperative outcomes, the average length of stay
(LOS) of the We found that the data was not distributed
regularly. The median duration of the procedures have done in
225 minutes, with the most prolonged duration of the operation
is 450 minutes. Median of intraoperative blood loss was around
50 mL, with one patient loss his blood around 500 mL (see table
2).patients is 8.6 ± 1.6 days, with most of the patients feel mild
pain in average visual analogue score 3.5 ± 1.1 on the first postoperative day. The average time needed to recover to daily
activity was 7.3 ± 1.8 days.

popliteal arteries in patients with a high level of urea. The high
level of urea was due to hemodynamic imbalance found in CLI
patients, which would affect the renal urea excretion. 22 Gary et
al. found a difference in subjects with normal urea level and
high urea level. Even though serum creatinine in this study was
relatively within normal limits.22 There were several factors
affecting creatinine levels, such as old age, congestive heart
failure, malnutrition, and a catabolic state. PT and aPTT level
was normal in our subjects. No previous studies stated any
relation between PT and aPTT with CLI.22 But, coagulopathy
was closely related to vessel occlusion, which could be
evaluated using coagulation panel and fibrinolytic system.

Discussion

The total cholesterol level in our study was 190 mg/dl, which
was normal. Our mean triglyceride level was a little higher than
the upper limit, i.e., 151.5 mg/dL. Cholesterol and triglyceride
levels were known to be risk factors of CLI11; cholesterol level
more than 270 mg/dL had a higher chance of having
intermittent claudication. High triglyceride also found in CLI
patients.11 High cholesterol and triglyceride mean a higher
incidence of atherosclerosis, which potentially causing CLI.
Our standard level of cholesterol and triglyceride probably
caused by previous cholesterol-lowering therapy. The high
level of random blood glucose and HbA1C in our subjects
possibly related to our high incidence of diabetic patients.
Diabetes was also the leading risk factor of CLI. 11 The other
risk factor was a smoking habit, which found in 41% of our
subjects.

The mean age of the subjects in our study was 58 years old, and
most of them were males (51.5%). The mean age in our study
was relatively younger than other previous CLI intervention
studies. A study by Kanolkar and Ephrem in India had a mean
age of subjects of 65 years old,1 and a study by Iida et al. in
Japan had older mean age, i.e., 73 years old.18 Epidemiology
records in other countries such as Australia, America, and
Germany noted an increasing incidence of CLI in older
individuals (75-80 years old).19 It concluded that CLI patients
in Indonesia were younger. Different lifestyles could explain
this difference in mean age among countries.
The most common site of CLI in our study was the femoral
artery (46.8%), followed by popliteal artery (20.7%), anterior
tibial artery (12.6%), and posterior tibial artery (10.8%). Other
arteries, iliac, and peroneal artery, had a lower incidence. This
finding differed from Khanolkar and Epherem's study, which
stated the infra-popliteal artery as the most common site of
CLI.1 The high prevalence in femoral and popliteal arteries
might be caused by a chronic narrowing in diabetes mellitus or
lousy lifestyle.20 The incidence of diabetes mellitus in our
subjects was quite high, which could explain the possible
chronic vessel narrowing. The anatomical site in which the
popliteal artery was compressed in joint articulation might also
play a role.

Several characteristics were statistically significant between
the two intervention groups, which might affect the final
analysis. Those characteristics were a median of random blood
glucose, HbA1C, and prevalence of diabetes mellitus. These
findings might be due to by our sampling method that did not
warrant randomization. Even though, in the clinical
perspective, the difference was not significant. The median
value of random blood glucose in both groups was within
normal limits, and HbA1C value in both groups was in the high
category. Therefore, we concluded that this difference might
not affect our analysis.

We found a below-normal value of hemoglobin and hematocrit
in our subjects; this could be caused by chronic inflammation
state in CLI. CLI patients commonly associated with other
chronic conditions (s), making it more possible to cause
anemia. Recurrent infection and several operative procedures
might also have affected the hemoglobin and hematocrit level.
The study by Shah et al. was also showed anemia in CLI
patients in England.21 Anemia might also be caused by
malnutrition and duration stay in the hospital. 21 The high
leukocyte level in our subjects considered related to chronic
inflammation as well. Several subjects had ulcer wounds,
which was vulnerable to infection, therefore increasing the risk
of leukocytosis.

The duration of wound healing was significantly between CLI
patients treated with balloon angioplasty and stent angioplasty.
The difference was 25 days (85 days in balloon angioplasty
group versus 60 days in-stent angiography group). We
considered this difference as significant clinically because it
was nearly a month. We defined duration as wound healing,
starting from patient admission until her/his ulcer healed. The
most crucial factor of CLI wound healing was the
revascularization strategy to bring back the perfusion to the
distal part of occlusion.23 Stent angiography, therefore, could
be considered a better revascularization strategy than balloon
angioplasty.

SGOT and SGPT levels of our subjects were within normal
limits. Until now, there was no literature stating the correlation
between SGOT/SGPT levels with CLI. Our median of urea
level was higher than normal (31 versus 20 mg/dL), but our
median creatinine was within the standard limit (0.9 mg/dL).
Increased urea, also described by Gary et al. study.22 This study
also found that disruption was higher in iliac, femoral, and

The better vessel patency could cause faster wound healing instent angiography compared to balloon angioplasty. A study by
Reed et al. showed a higher rate of re-admission after balloon
angioplasty compared to stent angioplasty, in which the
patients had re-occurrence or worsening of claudication and
resting pain.24 Stent angioplasty in smaller vessels was still a
controversy, considering the risk of thrombosis and intimal
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hyperplasia. Another study also stated that stent placement into
a vessel had good patency and no re-obstruction noted after 24
months of intervention.20 Stent angioplasty could be used in
small vessels if balloon angioplasty failed. The efficacy of stent
angioplasty in sub-intimal recanalization and calcification was
limited.25 Furthermore, balloon angioplasty had lower
durability due to the re-narrowing of vessels after the
intervention. The minus side of stent angioplasty was the
anatomical restriction and risk of stent fracture, which might
cause re-stenosis and re-occlusion.20 Risk factors of stent
fracture were stent type, length, and number. Balloon
angioplasty could be done for a vessel less than 2 mm in
diameter, a type of vessel that cannot be done by stent
angioplasty. Balloon angioplasty in the infra-popliteal artery
also showed good results, with 75% limb salvage in 12
months.25 Another study stated good limb salvage with balloon
angioplasty in severe tibial disease. On the contrary, the stent
in infra-popliteal had the risk of dissection and calcification due
to imperfect stent expansion. Extensive stenting was also
increasing the risk of reduced flow and thrombosis. 20
We found an insignificant difference in resting pain and
amputation rates between the two groups. This finding was
similar to previous studies. However, amputation incidence in
our subjects was relatively high, i.e., 42%. Another study by
Hedayati et al. showed their amputation rate was 6-7% in 12
months for CLI patients underwent endovascular
intervention.26 The gap between amputation rate might be
caused by different geographic and epidemiologic profile. The
previous study stated no major amputation after 12 months of
intervention in aorto-iliac and femoro-popliteal disease.20
Resting pain was improved almost in all subjects in that study.
Improvement of resting pain was a direct effect of revascularization.
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Conclusion
TThe duration of wound healing was significantly between CLI
patients treated with balloon angioplasty and stent angioplasty
by 25 days. Stent angiography resulted in shorter wound
healing compared to balloon angioplasty. Stent angioplasty is a
better method than balloon angioplasty for wound healing in
patients with CLI.
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